240
Views
5
CrossRef citations to date
0
Altmetric
Pharmacoeconomics and Outcomes in Pain and Palliative Care

Opioid Prescribing Patterns and Costs in a Large Group of Patients in Colombia

Pages 57-65 | Received 21 Oct 2016, Accepted 18 Dec 2016, Published online: 10 Feb 2017

References

  • Task Force on Taxonomy of the International Association for the Study of Pain. Classification of chronic pain descriptions of chronic pain syndromes and definitions of pain terms. Second Edition. Seattle, WA. International Association for the Study of Pain. 1994. Available at http://www.iasp-pain.org/files/Content/ContentFolders/Publications2/FreeBooks/Classification-of-Chronic-Pain.pdf. Accessed November 1, 2016.
  • Vargas-Schaffer G. Is the WHO analgesic ladder still valid? Twenty-four years of experience. Can Fam Physician. 2010;56:514–517.
  • Bohnert AS, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305:1315–1321.
  • Haffajee RL, Jena AB, Weiner SG. Mandatory use of prescription drug monitoring programs. JAMA. 2015;313:891–892.
  • Karanges EA, Blanch B, Buckley NA, Pearson SA. Twenty-five years of prescription opioid use in Australia: a whole-of-population analysis using pharmaceutical claims. Br J Clin Pharmacol. 2016;82:255–267.
  • Smolina K, Gladstone E, Morgan SG. Determinants of trends in prescription opioid use in British Columbia, Canada, 2005–2013. Pharmacoepidemiol Drug Saf. 2016;25:553–559.
  • Laxmaiah Manchikanti M, Vallejo R. Effectiveness of long-term opioid therapy for chronic non-cancer pain. Pain Physician. 2011;14:E133–E156.
  • Chou R, Turner JA, Devine EB, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015;162:276–286.
  • Nuckols TK, Anderson L, Popescu I, et al. Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain. Ann Intern Med. 2014;160:38–47.
  • Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016. MMWR Recomm Rep. 2016;65:1–49.
  • Dasgupta N, Funk MJ, Proescholdbell S, Hirsch A, Ribisl KM, Marshall S. Cohort study of the impact of high-dose opioid analgesics on overdose mortality. Pain Med. 2016;17:85–98.
  • Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010;152:85–92.
  • Chen LH, Hedegaard H, Warner M. Drug-poisoning deaths involving opioid analgesics: United States, 1999–2011. NCHS Data Brief. 2014(166):1–8.
  • World Health Organization. Introduction to Drug Utilization Research. Oslo, 2003. Available at http://apps.who.int/medicinedocs/pdf/s4876e/s4876e.pdf. Accessed November 1, 2016.
  • Machado-Alba JE, Morales-Plaza CD. [Antipsychotic prescription patterns in patients affiliated to the Social Security Health System in Colombia]. Biomedica. 2013;33:418–428.
  • Moyano J, Figueras A. A review of opioid prescription in a teaching hospital in Colombia. J Pain Res. 2012;5:237–242.
  • Birke H, Kurita GP, Sjøgren P, Højsted J, Simonsen MK, Juel K, Ekholm O. Chronic non-cancer pain and the epidemic prescription of opioids in the Danish population: trends from 2000 to 2013. Acta Anaesthesiol Scand. 2016;60(5):623–33.
  • Friesen KJ, Woelk C, Bugden S. Safety of fentanyl initiation according to past opioid exposure among patients newly prescribed fentanyl patches. CMAJ. 2016;188:648–653.
  • Shrestha S, Schofield P, Devkota R. A critical literature review on non-pharmacological approaches used by older people in chronic pain management. Indian J Gerontol. 2013;27:135–161.
  • Volkow ND, McLellan AT. Opioid abuse in chronic pain—misconceptions and mitigation strategies. N Engl J Med. 2016;374:1253–1263.
  • West NA, Dart RC. Prescription opioid exposures and adverse outcomes among older adults. Pharmacoepidemiol Drug Saf. 2016,25:539–544.
  • Colombia, Ministerio de la Protección Social. Resolución 1478 de 2006 “Por la cual se expiden normas para el control, seguimiento y vigilancia de la importación, exportación, procesamiento, síntesis, fabricación, distribución, dispensación, compra, venta, destrucción y uso de sustancias sometidas a fiscalización, medicamentos o cualquier otro producto que las contengan y sobre aquellas que son Monopolio del Estado”. Bogotá D.C., Colombia. https://www.invima.gov.co/images/pdf/medicamentos/resoluciones/resolucion%20001478%20de%202006.pdf. Accessed November 1, 2016.
  • Vallejos A, Ruano C, Latorre S, Calvache J. Perfil de uso y rango de dosis de analgésicos en un hospital de cuarto nivel en Bogotá. Rev Med Risaralda. 2016;22(1):11–4.
  • Brady KT, McCauley JL, Back SE. Prescription opioid misuse, abuse, and treatment in the United States: an update. Am J Psychiatry. 2015;173:18–26.
  • Moyano JR, Figueras A. The medical consumption of opioids in Colombia, 1997–2007. J Pain Palliat Care Pharmacother. 2010;24:367–373.
  • Rico MA, Kraychete DC, Iskandar AJ, et al. Use of opioids in Latin America: the need of an evidence-based change. Pain Med. 2016;17:704–716.
  • Davis MP, Walsh D, Lagman R, LeGrand SB. Controversies in pharmacotherapy of pain management. Lancet Oncol. 2005;6:696–704.
  • Mercadante S. Opioid combination: rationale and possible clinical applications. Ann Palliat Med. 2013;2:189–196.
  • Mercadante S. Efficacy and safety of dual opioid therapy. Expert Opin Drug Saf. 2014;13:1433–1436.
  • Nadeau SE. Opioids for chronic noncancer pain: to prescribe or not to prescribe—what is the question? Neurology. 2015;85:646–51.
  • Li L, Setoguchi S, Cabral H, Jick S. Opioid use for noncancer pain and risk of fracture in adults: a nested case-control study using the General Practice Research Database. Am J Epidemiol. 2013;178:559–569.
  • Miller M, Barber CW, Leatherman S, et al. Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy. JAMA Intern Med. 2015;175:608–615.
  • Smith HS. Combination opioid analgesics. Pain physician. 2007;11:201–214.
  • Hoban B, Larance B, Gisev N, et al. The use of paracetamol (acetaminophen) among a community sample of people with chronic non-cancer pain prescribed opioids. Int J Clin Pract. 2015;69:1366–1376.
  • Albertson TE, Walker VM Jr, Stebbins MR, Ashton EW, Owen KP, Sutter ME. A population study of the frequency of high-dose acetaminophen prescribing and dispensing. Ann Pharmacother. 2010;44:1191–1195.
  • Clark R, Fisher JE, Sketris IS, Johnston GM. Population prevalence of high dose paracetamol in dispensed paracetamol/opioid prescription combinations: an observational study. BMC Clin Pharmacol. 2012;12:11.
  • Mort JR, Shiyanbola OO, Ndehi LN, Xu Y, Stacy JN. Opioid-paracetamol prescription patterns and liver dysfunction. Drug Saf. 2011;34:1079–1088.
  • Food and Drug Administration. FDA reminds health care professionals to stop dispensing prescription combination drug products with more than 325 mg of acetaminophen. http://www.fda.gov/Drugs/DrugSafety/ucm394916.htm. Published 2014. Accessed July 2016.
  • Beakley BD, Kaye AM, Kaye AD. Tramadol, pharmacology, side effects, and serotonin syndrome: a review. Pain Physician. 2015;18:395–400.
  • Álvarez Y, Farré M. Farmacología de los opioides. Adicciones. 2005;17(Suppl 2):21–40.
  • Boscarino JA, Rukstalis M, Hoffman SN, et al. Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system. Addiction. 2010;105:1776–1782.
  • Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA. 2013;309:657–659.
  • Smith HS, Laufer A. Opioid induced nausea and vomiting. Eur J Pharmacol. 2014;722:67–78.
  • Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain. 2004;112:372–380.
  • Machado-Alba JE, Morales-Plaza CD, Solarte-Gómez MJ. [Antidepressant prescription patterns in patients affiliated with the General Social Security Health System of Colombia]. Rev Pan Salud Publica. 2011;30:461–468.
  • Gómez Juanes V, Candás Villar MA, Fidalgo González S, et al. Análisis del consumo de medicamentos utilizando indicadores de calidad en la prescripción. Aten Primaria. 2000;25:618–624.
  • Dart RC, Surratt HL, Cicero TJ, et al. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med. 2015;372:241–248.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.